Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events
Javier Martínez‐Sanz(Instituto Cajal), M. Mar Alonso, Esperanza Merino(Bellvitge University Hospital), Rafael Rubio(Bellvitge University Hospital), Iván Agea, Francesc Vidal(Institut de Recerca Biomèdica Catalunya Sud), Jehovana Hernández, Ana López Lirola, Féderico García, Andrés Ruiz Sancho(Instituto de Investigación Biosanitaria de Granada), Juan Berenguer(Hospital General Universitario Gregorio Marañón), Elba Mauleón, Inmaculada Jarrín, Sergio Reus(Instituto de Salud Carlos III), José Sánchez–Payá(Biogipuzkoa Health Research Institute), Enrique Bernal(Hospital Reina Sofía de Murcia), Marta Rosas Cancio-Suárez(Instituto de Salud Carlos III), Livia Giner, Noemí Cabello(Hospital Clínico San Carlos), Jorge Díaz-Álvarez(Instituto Cajal), Joaquín Portilla(Hospital General Universitario de Alicante Doctor Balmis), Julián Olalla(Hospital Costa del Sol), Eva Poveda(Madrid Health Service), Diego Torrús, Sergio Serrano‐Villar, Irene Portilla, María Ángeles Muñoz‐Fernández(Hospital General Universitario Gregorio Marañón), Marta Rava(Instituto de Salud Carlos III), Juan Luís Gómez, Julia Portilla(Hospital Costa del Sol), Dácil García, Raquel Ron, Vicente Boix, Maria Gonzalez, Juan Carlos Rodrı́guez, Santiago Moreno(Hospital Universitario Ramón y Cajal), Verónica Pérez, David Dalmau(University Hospital Mútua de Terrassa), Cristina Moreno(Universidad de Alcalá), Ma Luisa Masó Navarro, José Antonio Iribarren(Biogipuzkoa Health Research Institute), Gema García, Juan González, Rebeca Izquierdo, Felícitas Díaz-Flores, Félix Gutiérrez(Evidence (Italy))
Cited by 40
Related Papers
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|720
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
|AIDS|2002|443
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
|The Lancet HIV|2020|396
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection
|EBioMedicine|2021|239
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
|International Journal of Infectious Diseases|2020|226